The first comprehensive definition of DED was published in 1995 on the basis of consensus from the National Eye Institute (NEI) Industry Working Group on Clinical Trials in DED.
1 In the report, DED is defined as follows:
“Dry eye is a disorder of the tear film due to tear deficiency or excessive evaporation, which causes damage to the interpalpebral ocular surface and is associated with symptoms of ocular discomfort.”
The definition clearly states that changes in the tear film are the cause of DED, which subsequently cause irritating symptoms and epithelial abnormalities. It also suggests that tear deficiency and excessive evaporation are the major causes of DED. This concept was reflected in the classification in this publication. DED was divided into two major categories involving tear deficient and evaporative, and then was further subclassified into a range of intrinsic and extrinsic causes. It is important that the definition uses the term “disorder” and not “disease.” This definition and classification scheme have influenced subsequent DED studies and clinical approaches, including the Preferred Practice Pattern reported by the American Academy of Ophthalmology in 2013
2 and others.
3–7
The second major progress was made in the early 2000s, and the results were published in the report of the International DEWS of the TFOS in 2007.
3 This report states:
“Dry eye is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. It is accompanied by increased osmolarity of the tear film and inflammation of the ocular surface.”
This definition proposes several differences from the previous NEI report. First, DED was considered to be a disease caused by abnormalities in either tears or the ocular surface. Tears were not considered to be the sole cause of DED, and changes in the epithelium could cause abnormalities in tears. In this regard, DED was considered to be a dysfunction of the integrated functional unit comprising the lacrimal glands, ocular surface, eyelids, and sensory and motor nerves.
8 Second, DED might cause visual disturbances.
9–11 Third, increased osmolarity and ocular surface inflammation were included in the DED definition.
12–14 Inclusion of these pathogenic factors in the definition of DED was new and contrasted with previous NEI reports. The definition caused controversy among researchers regarding whether the inflammation and hyperosmolarity had a casual or causal relationship with DED. The classification system of the DEWS report basically revised the 1995 NEI report, with aqueous-deficient DED and evaporative dry eye as the major two subtypes (
Fig. 1). Aqueous-deficient was further classified into Sjögren and non-Sjögren categories. Evaporative dry eye was subclassified into intrinsic and extrinsic categories, and they were further classified as resulting from a range of causes.
In a recent revision, published in 2017, dealing with the DED definition and classification in the DEWS II report, the following definition of DED is provided:
“A multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles.”
4
This definition is basically a minor revision of DEWS, which used the term “homeostasis of the tear film” to suggest that a variety of factors could influence the homeostasis. The definition followed the previous one by describing factors that were important in the pathogenesis of DED, which included tear film instability, hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities. Neurosensory abnormalities were included in the definition for the first time, reflecting recent interest in the importance of alterations in pain and sensations in DED.
15 The classification system succeeded the recent DEWS II reports with several modifications.
4 The newly proposed classification scheme considered cases in which patients exhibited DED symptoms without obvious DED signs, or presented with symptoms that were not characteristic of DED. The former were cases with either a preclinical state of DED or neuropathic pain in which the somatosensory system was affected. The latter was considered to be related to reduced corneal sensitivity (a neurotrophic condition). Eyes with both signs and symptoms were classified as either aqueous-deficient or evaporative dry eye. Although this part of the classification was basically the same as previous classifications, there was a slight modification to clarify that there was a significant number of eyes that had both aqueous-deficient and evaporative components, so that these two subcategories were not exclusive.
In the diagnosis report, DEWS II listed a variety of diagnostic tests, which included questionnaires, tear film tests, epithelial abnormalities, and others.
16 Although the report did not propose specific diagnostic criteria, it indicated the most appropriate (efficacious) tests to diagnose and monitor DED (
Fig. 2).
There are other groups that proposed definitions and/or diagnostic criteria. In 2006, a panel of international DED specialists established a consensus using the Delphi approach. In this report, the use of “dysfunctional tear syndrome (DTS)” instead of DED was proposed.
17 The report concluded that treatment strategies should rely on symptoms and signs rather than tests. The panel defined clinical signs to be considered in assessing the severity of DTS, which were used to develop a severity-based treatment algorithm. A major aim of the report was to establish a treatment algorithm; no specific definition or diagnostic criteria were suggested.
The Korean Corneal Study Group suggested a DED definition and treatment algorithm in 2014. In the report, they define DED as “a disease of the ocular surface that is associated with tear film abnormalities.”
18 They proposed diagnostic criteria involving one or more symptoms (either irritating or visual symptoms), plus at least one objective sign including either ocular surface staining or tear film instability.
A European group also proposed diagnostic criteria for severe DED. In this report, Baudouin and associates
19 proposed that patients with a high ocular surface disease index (OSDI; >33) and increased corneal fluorescein score (≥3) were considered to have severe DED, whereas an OSDI <33 with a fluorescein score ≥3, OSDI ≥33 with a fluorescein score = 2, or an OSDI ≥33 with a fluorescein score <2 were considered as severe DED if there were different DED findings, such as impaired corneal sensitivity, a breakup time (BUT) <5 seconds, and additional criteria (
Fig. 3).